ID   KE-3
AC   CVCL_D883
SY   KE3
DR   JCRB; JCRB1883
DR   Wikidata; Q54899714
RX   PubMed=7671230;
RX   PubMed=9023415;
RX   PubMed=9178645;
RX   PubMed=11115554;
RX   PubMed=14532970;
RX   PubMed=20515944;
RX   PubMed=26512696;
CC   Population: Japanese.
CC   HLA typing: A*02:24; B*07,61; C*07 (PubMed=7671230).
CC   HLA typing: A*02:06,24:02; C*04:01,15:02 (PubMed=9023415).
CC   HLA typing: A*02:06,24:02; B*07,61; C*01:02,03:02 (PubMed=9178645).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): JCRB=JCRB1883
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11,12
ST   D16S539: 9,10,12
ST   D5S818: 9,10
ST   D7S820: 10,11
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 14,18
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 02-05-24; Version: 10
//
RX   PubMed=7671230;
RA   Nakao M., Yamana H., Imai Y., Toh Y., Toh U., Kimura A., Yanoma S.,
RA   Kakegawa T., Itoh K.;
RT   "HLA A2601-restricted CTLs recognize a peptide antigen expressed on
RT   squamous cell carcinoma.";
RL   Cancer Res. 55:4248-4252(1995).
//
RX   PubMed=9023415; DOI=10.1006/cimm.1996.1062;
RA   Seki N., Hoshino T., Kikuchi M., Hayashi A., Itoh K.;
RT   "HLA-A locus-restricted and tumor-specific CTLs in tumor-infiltrating
RT   lymphocytes of patients with non-small cell lung cancer.";
RL   Cell. Immunol. 175:101-110(1997).
//
RX   PubMed=9178645; DOI=10.1006/cimm.1997.1108;
RA   Nakao M., Sata M., Saitsu H., Yutani S., Kawamoto M., Kojiro M.,
RA   Itoh K.;
RT   "CD4+ hepatic cancer-specific cytotoxic T lymphocytes in patients with
RT   hepatocellular carcinoma.";
RL   Cell. Immunol. 177:176-181(1997).
//
RX   PubMed=11115554; DOI=10.3892/ijo.18.1.157;
RA   Fujii T., Kato S., Yamana H., Tanaka Y., Fujita H., Shirouzu K.,
RA   Morimatsu M.;
RT   "Expression of G1 cell cycle markers and the effect of
RT   adenovirus-mediated overexpression of p21Waf-1 in squamous cell
RT   carcinoma of the esophagus.";
RL   Int. J. Oncol. 18:157-163(2001).
//
RX   PubMed=14532970; DOI=10.3892/ijo.23.5.1309;
RA   Matono S., Tanaka T., Sueyoshi S., Yamana H., Fujita H., Shirouzu K.;
RT   "Bystander effect in suicide gene therapy is directly proportional to
RT   the degree of gap junctional intercellular communication in
RT   esophageal cancer.";
RL   Int. J. Oncol. 23:1309-1315(2003).
//
RX   PubMed=20515944; DOI=10.1158/1535-7163.MCT-09-0918; PMCID=PMC2884061;
RA   Seki N., Toh U., Sayers T.J., Fujii T., Miyagi M., Akagi Y.,
RA   Kusukawa J., Kage M., Shirouzu K., Yamana H.;
RT   "Bortezomib sensitizes human esophageal squamous cell carcinoma cells
RT   to TRAIL-mediated apoptosis via activation of both extrinsic and
RT   intrinsic apoptosis pathways.";
RL   Mol. Cancer Ther. 9:1842-1851(2010).
//
RX   PubMed=26512696; DOI=10.3390/cancers7040881; PMCID=PMC4695881;
RA   O'Callaghan C., Fanning L.J., Barry O.P.;
RT   "Hypermethylation of MAPK13 promoter in oesophageal squamous cell
RT   carcinoma is associated with loss of p38delta MAPK expression.";
RL   Cancers (Basel) 7:2124-2133(2015).
//